1. Home
  2. FATE vs JYNT Comparison

FATE vs JYNT Comparison

Compare FATE & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.80

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$8.33

Market Cap

118.2M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
FATE
JYNT
Founded
2007
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
125.6M
118.2M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
FATE
JYNT
Price
$2.80
$8.33
Analyst Decision
Buy
Strong Buy
Analyst Count
6
2
Target Price
$4.10
$17.00
AVG Volume (30 Days)
2.4M
53.1K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
29.88
133.93
EPS
N/A
0.14
Revenue
$6,646,000.00
$117,696,356.00
Revenue This Year
N/A
$12.23
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$91.33
Revenue Growth
N/A
15.49
52 Week Low
$0.91
$7.50
52 Week High
$3.23
$11.22

Technical Indicators

Market Signals
Indicator
FATE
JYNT
Relative Strength Index (RSI) 47.63 39.69
Support Level $1.01 $8.12
Resistance Level $3.22 $9.38
Average True Range (ATR) 0.17 0.28
MACD -0.03 -0.04
Stochastic Oscillator 37.50 6.85

Price Performance

Historical Comparison
FATE
JYNT

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

Share on Social Networks: